Lower Extremity Peripheral Artery Disease Guideline 2016
Добавлено: Ср ноя 30, 2016 1:06 am
2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease
A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
http://content.onlinejacc.org/article.a ... 1480451847
A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
http://content.onlinejacc.org/article.a ... 1480451847
Цитата для терапевтов:
Patients with symptomatic PAD should be initiated on antiplatelet therapy (aspirin 75-325 mg daily or clopidogrel 75 mg daily) and statin therapy, preferably atorvastatin 80 mg daily. Antihypertensive therapy, smoking cessation, and coordinated diabetes management should also be initiated.
Цитата для хирургов и интервенционалистов:
Revascularization is a reasonable treatment option for patients with lifestyle-limiting claudication and an inadequate response to medical management and exercise.
Endovascular intervention is effective for patients with lifestyle-limiting claudication and hemodynamically significant aortoiliac occlusive disease (Class I) or femoropopliteal disease (Class IIa).
Endovascular procedures should not be performed in patients with PAD solely to prevent progression to CLI (Class III: Harm)